A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Cricket in India is no less than a religion. The emotions when India lift the World Cups have been unparalleled to any other feeling for the cricket fans. The losses bring pain as the fans are deeply ...

Alibaba Group Holding’s artificial intelligence coding model Qwen 3 Coder has been gaining popularity globally amid intensified competition in the AI-assisted coding sector, according to data from a ...

Anthropic AI has increased the context window for their Claude Sonnet 4 model to a million tokens, which is 5 times more than its earlier limit of 200,000 tokens. This indicates that users will be ...

Sips and Sonnets is a cozy game where you play as an elderly women who brews tea and writes poems for her clientele. Meet Ms. Meadows, some clients, and get a peek into their lives in this Sips and ...

Following OpenAI’s big week filled with open models and GPT-5, Anthropic is on a streak of its own with AI announcements. The company today revealed that Claude Sonnet 4 now supports up to 1 million ...

Claude Sonnet 4 now has one million context tokens. As a result, the model can process much larger developer tasks. Developers can access it now, but API pricing does increase for certain requests. We ...

What if the future of coding wasn’t just about human ingenuity but also about the battle of AI giants? Imagine two innovative AI models—OpenAI’s GPT-5 and Anthropic’s Claude Sonnet—competing to build ...

In case you've faced some hurdles solving the clue, Sonnet's last six lines, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and ...

Sonnet BioTherapeutics Inc. SONN stock surged Monday amid high trading volume following news of a transformative business combination with Rorschach I, backed by Atlas Merchant Capital and Paradigm.

PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that it has entered into a definitive agreement (the ...